PL2310018T3 - Zastosowanie nifurtymoksu w leczeniu giardiozy - Google Patents

Zastosowanie nifurtymoksu w leczeniu giardiozy

Info

Publication number: PL2310018T3
Authority: PL; Poland
Prior art keywords: nifurtimox; treating giardiasis; giardiasis; treating
Prior art date: 2008-07-02

Application number

PL09772099T

Other languages

English (en)

Inventor

Gisela Greif

Achim Harder

Thomas Bach

Gabriele Petry

Eva-Maria Kruedewagen

Original Assignee

Bayer Ip Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-02

Filing date

2009-06-20

Publication date

2014-05-30

2009-06-20 Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh

2014-05-30 Publication of PL2310018T3 publication Critical patent/PL2310018T3/pl

Links

ARFHIAQFJWUCFH-IZZDOVSWSA-N Nifurtimox Chemical compound CC1CS(=O)(=O)CCN1\N=C\C1=CC=C([N+]([O-])=O)O1 ARFHIAQFJWUCFH-IZZDOVSWSA-N 0.000 title 1
201000006592 giardiasis Diseases 0.000 title 1
229960002644 nifurtimox Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Tropical Medicine & Parasitology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fodder In General (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Catching Or Destruction (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

PL09772099T 2008-07-02 2009-06-20 Zastosowanie nifurtymoksu w leczeniu giardiozy PL2310018T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102008031284A DE102008031284A1 (de)	2008-07-02	2008-07-02	Neue Bekämpfungsmöglichkeit der Giardiose
PCT/EP2009/004475 WO2010000399A1 (de)	2008-07-02	2009-06-20	Verwendung von nifurtimox zur behandlung der giardiose
EP09772099.9A EP2310018B1 (de)	2008-07-02	2009-06-20	Verwendung von nifurtimox zur behandlung der giardiasis

Publications (1)

Publication Number	Publication Date
PL2310018T3 true PL2310018T3 (pl)	2014-05-30

Family

ID=41077987

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09772099T PL2310018T3 (pl)	2008-07-02	2009-06-20	Zastosowanie nifurtymoksu w leczeniu giardiozy

Country Status (29)

Country	Link
US (1)	US8440612B2 (pl)
EP (1)	EP2310018B1 (pl)
JP (1)	JP5627579B2 (pl)
KR (1)	KR101720805B1 (pl)
CN (1)	CN102083441B (pl)
AR (1)	AR072425A1 (pl)
AU (1)	AU2009266125B2 (pl)
BR (1)	BRPI0913889B1 (pl)
CA (1)	CA2729730C (pl)
CL (2)	CL2010001577A1 (pl)
CO (1)	CO6321270A2 (pl)
CR (1)	CR20110022A (pl)
DE (1)	DE102008031284A1 (pl)
DK (1)	DK2310018T3 (pl)
DO (1)	DOP2010000405A (pl)
EC (1)	ECSP10010720A (pl)
ES (1)	ES2444581T3 (pl)
IL (1)	IL209698A (pl)
MX (1)	MX2010014446A (pl)
MY (1)	MY157007A (pl)
NI (1)	NI201100008A (pl)
NZ (1)	NZ590276A (pl)
PE (1)	PE20110283A1 (pl)
PL (1)	PL2310018T3 (pl)
RU (1)	RU2538713C9 (pl)
SV (1)	SV2011003785A (pl)
UA (1)	UA103328C2 (pl)
WO (1)	WO2010000399A1 (pl)
ZA (1)	ZA201009225B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012051251A1 (en) *	2010-10-12	2012-04-19	The Usa, As Repr. By The Secrt, Dept. Of Health & Human Serv. Office Of Technology Transfer,	Methods of treating giardiasis
CN114891070A (zh)	2015-05-20	2022-08-12	勃林格殷格翰动物保健美国公司	驱虫缩酚酸肽化合物
KR20220003663A (ko)	2015-12-28	2022-01-10	뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드	구충성 뎁시펩티드 화합물
MX2019005628A (es)	2016-11-16	2019-12-18	Boehringer Ingelheim Animal Health Usa Inc	Compuestos depsipeptidos antihelminticos.
EP3750527A1 (en) *	2019-06-13	2020-12-16	Bayer AG	Stable tablet formulation of nifurtimox and process for producing the same
CN114377018B (zh) *	2020-10-21	2024-02-06	中国医学科学院药物研究所	硝呋莫司在制备抗流感病毒药物中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1170957B (de) *	1962-11-23	1964-05-27	Bayer Ag	Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten
JPH081908B2 (ja) *	1987-07-22	1996-01-10	三菱電機株式会社	超格子半導体素子
NO176766C (no)	1989-02-07	1995-05-24	Meiji Seika Kaisha	Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
WO1993019053A1 (en) *	1992-03-17	1993-09-30	Fujisawa Pharmaceutical Co., Ltd.	Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de)	1992-06-11	1993-12-16	Bayer Ag	Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
AU695021B2 (en) *	1993-02-19	1998-08-06	Meiji Seika Kaisha Ltd.	PF1022 derivative cyclic depsipeptide
DE4317432A1 (de) *	1993-05-26	1994-12-01	Bayer Ag	Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de)	1993-05-26	1994-12-01	Bayer Ag	Octacyclodepsipeptide mit endoparasitizider Wirkung
US5646244A (en) *	1993-09-06	1997-07-08	Fujisawa Pharmaceutical Co., Ltd.	Cyclodepsipeptide compound
DE4401389A1 (de) *	1994-01-19	1995-07-20	Bayer Ag	Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) *	1994-02-24	1995-08-31	Bayer Ag	Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
DE4437198A1 (de)	1994-10-18	1996-04-25	Bayer Ag	Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
CN1162409C (zh)	1995-06-30	2004-08-18	藤泽药品工业株式会社	缩肽衍生物、其新型中间体以及中间体的制造方法
IL123776A (en) *	1995-09-22	2002-09-12	Bayer Ag	History of Cyclodepsipeptide 1022 PF
DE19545639A1 (de) *	1995-12-07	1997-06-12	Bayer Ag	Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
US6503881B2 (en) *	1996-08-21	2003-01-07	Micrologix Biotech Inc.	Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US5874630A (en) *	1998-01-06	1999-02-23	Occidental Chemical Corporation	Synthesis of mercaptans from alcohols
US6133228A (en) *	1998-05-28	2000-10-17	Firmenich Sa	Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or α-keto esters
DE19828047A1 (de) *	1998-06-24	1999-12-30	Bayer Ag	Substituierte Cyclooctadepsipeptide
KR20070086000A (ko) *	2004-11-12	2007-08-27	셀진 코포레이션	기생충성 질병의 치료 및 관리를 위한 면역조절성 화합물을사용하는 방법 및 조성물
DE102005033496A1 (de)	2005-07-19	2007-01-25	Bayer Healthcare Ag	Desinfektionsmittel

2008
- 2008-07-02 DE DE102008031284A patent/DE102008031284A1/de not_active Withdrawn
2009
- 2009-06-20 AU AU2009266125A patent/AU2009266125B2/en not_active Ceased
- 2009-06-20 MY MYPI2010006319A patent/MY157007A/en unknown
- 2009-06-20 KR KR1020117002111A patent/KR101720805B1/ko not_active Expired - Fee Related
- 2009-06-20 WO PCT/EP2009/004475 patent/WO2010000399A1/de not_active Ceased
- 2009-06-20 ES ES09772099.9T patent/ES2444581T3/es active Active
- 2009-06-20 US US13/000,715 patent/US8440612B2/en not_active Expired - Fee Related
- 2009-06-20 CN CN2009801255081A patent/CN102083441B/zh not_active Expired - Fee Related
- 2009-06-20 JP JP2011515179A patent/JP5627579B2/ja not_active Expired - Fee Related
- 2009-06-20 UA UAA201101135A patent/UA103328C2/uk unknown
- 2009-06-20 RU RU2011103475/15A patent/RU2538713C9/ru not_active IP Right Cessation
- 2009-06-20 BR BRPI0913889A patent/BRPI0913889B1/pt not_active IP Right Cessation
- 2009-06-20 MX MX2010014446A patent/MX2010014446A/es active IP Right Grant
- 2009-06-20 PL PL09772099T patent/PL2310018T3/pl unknown
- 2009-06-20 NZ NZ590276A patent/NZ590276A/xx not_active IP Right Cessation
- 2009-06-20 DK DK09772099.9T patent/DK2310018T3/da active
- 2009-06-20 CA CA2729730A patent/CA2729730C/en not_active Expired - Fee Related
- 2009-06-20 EP EP09772099.9A patent/EP2310018B1/de not_active Not-in-force
- 2009-06-20 PE PE2010001201A patent/PE20110283A1/es not_active Application Discontinuation
- 2009-06-30 AR ARP090102439A patent/AR072425A1/es not_active Application Discontinuation
2010
- 2010-12-01 IL IL209698A patent/IL209698A/en active IP Right Grant
- 2010-12-22 ZA ZA2010/09225A patent/ZA201009225B/en unknown
- 2010-12-27 EC EC2010010720A patent/ECSP10010720A/es unknown
- 2010-12-27 CO CO10162857A patent/CO6321270A2/es active IP Right Grant
- 2010-12-27 DO DO2010000405A patent/DOP2010000405A/es unknown
- 2010-12-27 CL CL2010001577A patent/CL2010001577A1/es unknown
2011
- 2011-01-03 SV SV2011003785A patent/SV2011003785A/es active IP Right Grant
- 2011-01-05 NI NI201100008A patent/NI201100008A/es unknown
- 2011-01-11 CR CR20110022A patent/CR20110022A/es unknown
2013
- 2013-03-15 CL CL2013000709A patent/CL2013000709A1/es unknown

Also Published As

Publication number	Publication date
ZA201009225B (en)	2012-03-28
HK1158113A1 (en)	2012-07-13
MX2010014446A (es)	2011-02-22
US8440612B2 (en)	2013-05-14
EP2310018A1 (de)	2011-04-20
WO2010000399A1 (de)	2010-01-07
US20110105388A1 (en)	2011-05-05
RU2011103475A (ru)	2012-08-10
KR101720805B1 (ko)	2017-03-28
CL2013000709A1 (es)	2013-08-23
RU2538713C9 (ru)	2015-08-20
AU2009266125A1 (en)	2010-01-07
EP2310018B1 (de)	2013-12-18
CR20110022A (es)	2011-05-10
CL2010001577A1 (es)	2011-05-06
AU2009266125B2 (en)	2015-06-04
AR072425A1 (es)	2010-08-25
SV2011003785A (es)	2011-05-20
CA2729730A1 (en)	2010-01-07
PE20110283A1 (es)	2011-05-07
CN102083441A (zh)	2011-06-01
UA103328C2 (uk)	2013-10-10
DK2310018T3 (da)	2014-03-24
DE102008031284A1 (de)	2010-01-07
JP5627579B2 (ja)	2014-11-19
JP2011526265A (ja)	2011-10-06
IL209698A0 (en)	2011-02-28
BRPI0913889B1 (pt)	2019-02-05
CO6321270A2 (es)	2011-09-20
KR20110031357A (ko)	2011-03-25
MY157007A (en)	2016-04-15
DOP2010000405A (es)	2011-01-15
BRPI0913889A2 (pt)	2015-10-27
CN102083441B (zh)	2013-07-24
NZ590276A (en)	2012-12-21
CA2729730C (en)	2016-03-22
ECSP10010720A (es)	2011-01-31
IL209698A (en)	2016-03-31
RU2538713C2 (ru)	2015-01-10
ES2444581T3 (es)	2014-02-25
NI201100008A (es)	2011-08-10

Publication	Publication Date	Title
IL208354A0 (en)	2010-12-30	Methods of treatment
ZA201101425B (en)	2011-10-26	Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative deseases
IL207752A0 (en)	2010-12-30	Methods of treating inflammation
IL207440A0 (en)	2010-12-30	Methods of treating chronic pain
ZA201008392B (en)	2016-07-27	Treatment of pluripotent cells
EP2331564A4 (en)	2013-02-20	PROCESS FOR TREATMENT OF IGNITION
IL217777A0 (en)	2012-03-29	Methods for treatment of pain
NO2016023I1 (no)	2016-12-14	Glycerol fenylbutyrat
IL209488A0 (en)	2011-01-31	Inhibitors of akt activity
EP2303852A4 (en)	2011-12-28	ACTIVITY INHIBITORS AKT
EP2306825A4 (en)	2011-12-28	HAMMER OF ACT ACTIVITY
HRP20181877T1 (hr)	2019-01-11	Postupci za liječenje lijekovima koji uklanjaju amonijak
ZA201009225B (en)	2012-03-28	Use of nifurtimox for treating giardiasis
IL209999A0 (en)	2011-02-28	Nifurtimox for treating diseases caused by trichomonadida
EP2303277A4 (en)	2011-08-17	HAMMER OF ACT ACTIVITY
EP2164494A4 (en)	2010-06-02	Methods of Treatment
ZA201107708B (en)	2012-07-25	Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
EP2303017A4 (en)	2011-06-15	HAMMER OF ACT ACTIVITY
GB0723100D0 (en)	2008-01-02	Treatment of HFnEF
PT2244572T (pt)	2016-07-14	Utilização de congéneres de ibogamina para tratar obesidade
EP2303258A4 (en)	2012-03-14	ACTIVITY INHIBITORS AKT
GB2460445B (en)	2012-07-11	Treatment of ringworm
EP2203432A4 (en)	2011-04-27	PROCESSING METHOD
GB0700969D0 (en)	2007-02-28	Methods of treatment
GB0823435D0 (en)	2009-01-28	Method of treatment